Evidence-Based Complementary and Alternative MedicineVolume 2012 (2012), Article ID 925824, 13 pagesdoi:10.1155/2012/925824

Research Article

Phyllanthus urinaria Induces Apoptosis in Human Osteosarcoma 143B Cells via Activation of Fas/FasL- and Mitochondria-Mediated Pathways

Hsin-Yi Wu,¹ Tsu-Kung Lin,² Hsiao-Mei Kuo,³ Ya-Ling Huang,¹ Chia-Wei Liou,² Pei-Wen Wang,⁴ Jiin-Haur Chuang,⁵ and Sheng-Teng Huang¹

¹Department of Chinese Medicine and Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan²Department of Neurology and Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan³Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan⁴Department of Internal Medicine and Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan⁵Division of Pediatric Surgery and Mitochondrial Research Unit, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan

Received 11 October 2011; Accepted 7 November 2011

Academic Editor: Il-Moo Chang

Copyright © 2012 Hsin-Yi Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Phyllanthus urinaria (P. urinaria), in this study, was used for the treatment of human osteosarcoma cells, which is one of the tough malignancies with few therapeutic modalities. Herein, we demonstrated that P. urinaria inhibited human osteosarcoma 143B cells growth through an apoptotic extrinsic pathway to activate Fas receptor/ligand expression. Both intracellular and mitochondrial reactive oxygen species were increased to lead to alterations of mitochondrial membrane permeability and Bcl-2 family including upregulation of Bid, tBid, and Bax and downregulation of Bcl-2. P. urinaria triggered an intrinsic pathway and amplified the caspase cascade to induce apoptosis of 143B cells. However, upregulation of both intracellular and mitochondrial reactive oxygen species and the sequential membrane potential change were less pronounced in the mitochondrial respiratory-defective 143Bρ ⁰ cells compared with the 143B cells. This study offers the evidence that mitochondria are essential for the anticancer mechanism induced by P. urinaria through both extrinsic and intrinsic pathways.

1. Introduction

Phyllanthus urinaria, one of the species belonging to the genus Phyllanthus (Euphorbiaceae), is used as a traditional folk medicine for the treatment of several diseases including hepatitis B [1], nephrolithiasis [2], and some painful disorders [3]. Recent extensive studies have shown that this title plant exhibits many biological and pharmacological functions in vitro and in vivo, such as anticancer, cardioprotective, hepatoprotective, antiangiogenic, antioxidant, antisemicarbazide-sensitive amine oxidase, and antihypertensive effects [4–11].

The antitumor effect of Phyllanthus species was first verified by its activity against murine B-16 melanoma and P-388 leukemia [8]. Our previous study demonstrated that the aqueous extract of P. urinaria could induce apoptosis in human cancer cells derived from several different origins [12]. Chudapongse et al. reported that P. urinaria could inhibit Hep G2 cell proliferation by acting as an uncoupler and inhibitor of mitochondrial-oxidative phosphorylation [13]. Meanwhile, the water extract of P. urinaria exhibited an anticancer effect in an in vivo study not only through apoptosis, but also antiangiogenesis pathways in C57BL/6J mice with implanted Lewis lung carcinoma cells [14]. Tang et al. also proved that Phyllanthus species displayed cytotoxic effects on prostate cells and human skin melanoma through modulating the cell cycle and inducing apoptosis [15].

Apoptosis, also called programmed cell death, is a pathway of cell death characterized by several morphological and biochemical events [16]. Cell apoptosis is initiated by extracellular and intracellular signals via two main pathways, the death receptor- and mitochondria-mediated pathways [17]. Mitochondria are commonly involved in the death stimuli through the intrinsic (mitochondrial) pathway of apoptosis, which is the major mechanism of apoptosis in all mammalian cells. This pathway of apoptosis leads to an increase of mitochondrial permeability and the release of proapoptotic molecules (such as cytochrome c, apoptosis-inducing factor and Smac/DIABLO) from the intermembrane space of the mitochondria into the cytosol, thereby activating the caspase-cascade system [18, 19]. Mitochondrial permeability transition (MPT), first characterized by Hunter et al. [20], has been implicated as playing a critical role in the development of apoptotic cell death. Various pathologies can result from oxidative stress-induced apoptotic signaling that is consequent to increases in reactive oxygen species (ROS) and/or decreases in antioxidants, disruption of intracellular redox homeostasis, and irreversible oxidative modifications of lipids, proteins, or DNA [17]. It has been shown that the accumulation of ROS, Ca2+ toxicity, and ischemia damage induce permeability transition pore opening, whereas cyclosporin A (CsA) blocks opening which protects cells from death [21, 22]. It is now well known that the disruption of the apoptotic process through the mitochondria-dependent cell apoptotic pathway is involved in neoplastic transformation and tumor growth [23]. In our previous investigation, the pretreatment with cyclosporine A, an MPT pore inhibitor, reduced P. urinaria-induced Lewis lung carcinoma cell apoptosis suggesting that mitochondria are important for the anticancer effect. However, the mechanism of action remains unclear [14].

As we know, osteosarcoma is one of the tough malignancies for which few therapeutic approaches are effective. Therefore, we aimed to determine whether P. urinaria would lead to osteosarcoma cell apoptosis, and approach the relevant molecular mechanisms. We used human osteosarcoma 143B and mitochondrial DNA-deleted 143Bρ ⁰ cells to provide evidence that reactive oxidative respiration, mitochondrial membrane potential, and the sequential induction of caspase cascade were required for the antitumor effect of P. urinaria.

2. Materials and Methods

2.1. Preparation of P. urinaria Extract

The P. urinaria used in this study was identified by Dr. Rong-Chi Yang, the chief of the Chinese Herbal Pharmacy in Chang Gung Memorial Hospital, based on the definition described in Flora of Taiwan [24]. The voucher specimen of P. urinaria was deposited and numbered “173156” in the herbarium of National Taiwan University. The extract was prepared according to the quality standards following the GMP (good manufacturing practice) guidelines in Taiwan. The whole plant was minced and mixed with 100°C hot water in the proportion of 1 : 20 (w/v) for 4 hours and repeated for another 4 hours after adding the same amount of water again. The resulting crude extract was filtered and lyophilized down to dry powder. On average, the yield was 26.4% (w/w) from the whole P. urinaria plant. The P. urinaria extract used in the experiments was prepared by dissolving the dry powder extracted from 100 mg of the original whole plant in 1 mL sterile water, filtered and used as a 100 mg/mL stock.

2.2. Mass Spectrometry (MS)

High-performance liquid chromatography was performed using a Shimadzu SIL-20A LITE system (Shimadzu Corporation, Columbia, MD, USA). A Shimadzu SPD-10AV UV-Vis Detector was used at λ = 270 nm. The chromatographic separation was carried out on an Agilent Zorbax Eclipse XD8-C18 column (4.6 × 150 mm i.d.; 3.5 μm particle size) eluted with mixtures of 0.01% trifluoroacetic acid (aq) (A) and acetonitrile (B). The linear gradient program was set from 95 : 5 (A : B, v/v) to 80 : 20 in 22 min, then the concentration of acetonitrile was increased from 20% to 30% in the following 28 minutes. The flow rate was 0.6 mL/min. Each sample injecting volume was 30 μL. Mass spectra were acquired using an LTQ XL Mass Spectrometer (Thermo Electron Corp, San Jose, CA, USA) equipped with an electrospray ionization source operated in the negative mode using the following conditions: spray voltage (4.5 kV), heated capillary temperature (245°C); capillary voltage 47 V, and tube lens offset (5.25 V). Nitrogen was used as the sheath and auxiliary gas at 35 and 10 units, respectively. MSn experiments were carried out using helium as the collision gas. Data acquisition and analysis were accomplished with Xcalibur software version 2.0 (Thermo Electron Corporation). Gallic acid and ellagic acid (Sigma-Aldrich Corporation, WI, USA) were used as reference compounds and dissolved separately in methanol (MeOH).

2.3. Cell Culture and Generation of 143Bρ ⁰ Cells

Human 143B osteosarcoma (purchased from Food Industry Research and Development Institute, Taiwan) were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum at 37°C in 5% CO2. FBS was thawed at 37°C and then heated to 56°C for 30 min for heat inactivation. Production and culturing of 143Bρ ⁰ cells require growth medium containing 1 mM pyruvate and 50 μg/mL uridine (143Bρ ⁰ medium) to support growth [25]. The 143Bρ ⁰ cells were produced by culturing 143B osteosarcoma cells in the presence of ethidium bromide (EtBr, 50 ng/mL) for 8 weeks. Cells were subcultured every 2-3 days and kept in 50%–70% of confluence. The mtDNA-encoded subunit 2 of cytochrome c oxidase is undetectable for 143Bρ ⁰ cells using Western blotting. To examine the effect of P. urinaria extract, cells at 70% confluence were treated with 0~3 mg/mL of P. urinaria extract for 24 and 48 hours.

2.4. MTT Assay

Human osteosarcoma 143B and 143Bρ ⁰ cells with or without P. urinaria treatment were washed once with PBS, followed by the addition of 1 mL DMEM containing 0.05 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2 and 5-diphenyltetrazolium bromide (MTT; Sigma). After incubation at 37°C for 1 hour, the media were removed and the formazan crystals in the cells were dissolved in 1 mL DMSO for OD (optical density) reading at 570 nm using a spectrophotometer.

2.5. Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick End-Labeling (TUNEL) Staining

The TUNEL assay was used to detect DNA fragmentation. 143B and 143Bρ ⁰ cells plated on slides with or without P. urinaria treatment for 24 and 48 hours were fixed with 4% methanol-free formaldehyde (pH 7.4) for 5 minutes at 4°C and washed with PBS. TUNEL analysis was performed using an in situ Cell Death Detection Kit Fluorescein (Roche Molecular Biochemicals; Indianapolis, IN) according to the manufacturer’s protocol. TUNEL-positive cells were visualized by immunofluorescent microscopy. TUNEL-positive cells containing fluorescence were identified by colocalization with DAPI and by morphology. The slides were viewed under a fluorescence microscope with green fluorescence set at 520 nm. The cells stained green indicated apoptotic cells.

2.6. Annexin V-FITC/Propidium Iodide Staining

143B and 143Bρ ⁰ cells with or without P. urinaria treatment were harvested and washed twice with cold PBS, then resuspended in 1X binding buffer at a concentration of 6 × 105 cells/mL. 100 μL of the solution (6 × 104 cells) was then transferred to a 5 mL culture tube. All samples were processed for annexin V labeling according to the manufacturer’s instructions. Briefly, cells were resuspended in 100 μL of 1x annexin V binding buffer (BD Biosciences) and were fluorescently labeled for the simultaneous detection of apoptotic and necrotic cells by adding 5 μL of annexin V-FITC (BD Biosciences) and 5 μL of 1 mg/mL propidium iodide (PI) to each sample. Samples were gently mixed and incubated at room temperature in the dark for 30 min. At the end of the incubation, 400 μg of 1X binding buffer was added to each sample and the sample was analyzed using a flow cytometer (Becton Dickinson) equipped with CellQuest software.

2.7. Detection of ROS

Intracellular ROS were evaluated by determining the level of hydrogen peroxide (H₂O₂) using a 6-carboxy-2, 7-dichlorodihydrofluorescein diacetate (DCFDA) (Sigma) fluorescent probe. In the presence of H₂O₂, DCFDA is converted into 2, 7-dichlorodifluorescein (DCF), which can be detected by flow cytometry. Briefly, 6 × 105 cells were plated in six-well plates and allowed to attach for 16–18 hours. After being treated with P. urinaria at the concentration of 0–3 mg/mL for 24 hours or 48 hours, the cells were incubated with 5 μM DCFDA for an additional 30 min, followed by washing and resuspending in PBS. The fluorescence was detected using a BD Biosciences FACScan system.

2.8. Mitochondrial ROS Determination

P. urinaria-induced mitochondrial superoxide () production was quantified by MitoSOX Red, a redox-sensitive dye composed of hydroethidine linked by a hexyl carbon chain to a triphenylphosphonium group to target the mitochondrial matrix because of the negative membrane potential across the inner mitochondrial membrane. 143B and 143Bρ ⁰ cells with or without P. urinaria treatment for 24 and 48 hours were washed once with PBS. The cells were then loaded with MitoSOX Red (10 μM) at 37°C for 10 minutes, washed, and used for imaging using immunofluorescence microscopy.

2.9. Measurement of Mitochondrial Membrane Potential (ΔΨm)

6 × 10⁵ cells were plated in six-well plates and allowed to attach for 16–18 hours. After being treated with P. urinaria at the concentration of 0–3 mg/mL for 24 hours or 48 hours, the cells were harvested by treatment with trypsin, washed in phosphate-buffered saline (PBS), and resuspended in 200 ng/mL of Rhodamine 123 (Invitrogen). After incubation for 30 min at 37°C, the cells were washed three times and resuspended in 500 μL of PBS. Cytofluorimetric analysis was performed using a fluorescence-activated cell scanner machine (BD Biosciences FACScan system).

2.10. Immunofluorescence and Flow Cytometry Analysis

143B and 143Bρ ⁰ cells with or without P. urinaria treatment for 24 and 48 hours were permeabilized using buffer containing 1.5% normal goat serum and 0.2% Triton X-100 in PBS, incubated with Fas and FasL antibodies (1 : 100) for 1 hour, then incubated with Alexa 546 or 488-conjugated secondary antibodies for 30 minutes at room temperature. DAPI was used to stain the DNA/nuclei before mounting in antifade media, and the slides were visualized under a fluorescence microscope (1000X). The surface FasL expressions in the 143B and 143Bρ ⁰ cells were determined by flow cytometry analysis. Cells with or without P. urinaria treatment for 24 and 48 hours were trypsinized and incubated with FasL antibody (1 : 100) in Flow Cytometry Staining Buffer (eBioscience; San Diego, CA, USA) at 37°C for 1 hour. After washing with PBS twice, the cells were incubated with Alexa 488-conjugated secondary antibodies (1 : 200) at 37°C for 1 hour, washed with PBS twice, and resuspended in PBS for analysis in a flow cytometer (BD Biosciences, San Jose, CA, USA).

2.11. Western Blot Analysis

The cell lysates from 143B and 143Bρ ⁰ cells with or without treatment of P. urinaria were obtained, and protein concentrations were determined by the Bradford method (Bio-Rad, CA, USA). Samples with equal amount of proteins were subjected to 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto a polyvinylidene difluoride (PVDF) (Millipore, Bedford, MA, USA) membrane. The membrane was incubated at room temperature in blocking solution (10% nonfat milk) for 1 hour, followed by incubation for 2 hours in blocking solution containing an appropriate dilution (1 : 1000) of primary antibody, for example, anti-cleaved caspase-3, anti-cleaved caspase-8, anti-cleaved caspase-9, anti-Bax, anti-Bcl-2, and anti-Bid antibodies (Cell Signaling Technology). After washing, the membrane was incubated in PBS containing goat anti-rabbit IgG conjugated with horseradish peroxidase (Sigma, St. Louis, MO, USA) for 1 hour. The membrane was washed and the positive signals were developed with an Enhanced Chemiluminescence (ECL) system (Amersham Pharmacia Biotech). Membranes were exposed to Fuji medical X-ray film (Fuji Ltd., Tokyo, Japan) for 30 minutes. The β-actin expression was used as the internal control.

2.12. Statistical Analysis

All statistical analyses are performed using SigmaStat statistical software (version 2.0, Jandel Scientific, CA, USA). Results are represented as means ± standard deviation (SD). ANOVA was carried out when multiple comparisons were evaluated. Values were considered to be significant at a value less than 0.05. All experiments were repeated at least three times independently.

3. Results

3.1. Chemical Chromatography of the Aqueous Extract of P. urinaria

Analysis of the water extracts of P. urinaria by high performance liquid chromatography (HPLC) led to the identification of twelve compounds as shown in Table 1 [26]. The mass structures of these compounds were tentatively assigned based on mass data mining from existing literature. Compound 1 (Rt at 5.8 min) was determined to be 170 by liquid chromatography electrospray ionization tandem mass spectrometry (LC/(-)ESI-MS), yielding [M-H]-at m/z 169. The major fragment was shown at m/z 151 (M-H-H2O) and 125 (M-COOH), consistent with the structure of gallic acid [27]. Compound 3 (Rt at 18.0 min) and compound 9 (Rt at 23.3 min) were determined to be 292 and 248, yielding [M-H]-at m/z 291 and 247, respectively. The major fragment of compound 3 was shown at m/z 247 (M-COOH), and the minor fragment ions were the same as compound 9. Thus, the determined mass of compound 3 was 44 higher than compound 9, suggesting a carboxylic acid derivative of compound 9. By searching the bioactive components previously found in Phyllanthus species [3, 27], compound 3 and compound 9 were assigned as brevifolin carboxylic acid and brevifolin, respectively. LC/(-)ESI-MS analysis of compound 4 (Rt at 19.0 min) produced the same [M-H]-at m/z 291 as compound 3. (-)CAD-MS/MS (collision activated decomposition mass spectrum) analysis of compound 4 yielded intense product ions at m/z 247 (M-COOH), 203 (M-2COOH). Compared with the mass and mass fragments of compounds found in other Phyllanthus species, the structure of compound 4 was assigned as phyllanthusiin E [28]. LC/(-)ESI-MS analysis of compound 5 (Rt at 19.5 min), compound 6 (Rt at 20.5 min), compound 7 (Rt at 21.2 min), compound 8 (Rt at 22.8 min), compound 10 (Rt at 24.2 min), and compound 11 (Rt at 24.6 min) yielded [M-H]- at m/z 633, 951, 953, 925, 969, and 924, respectively. (-)CAD-MS/MS analysis of all these components yielded intense product ions at m/z 633 and 301, resulting from the loss of the hexahydroxydiphenoyl and/or galloyl moiety fragments [29]. These ions are significant fragments of ellagitannins. After comparing the mass and other minor fragment ions with tannins found in other Phyllanthus species, the structures of these compounds were assigned as corilagin [27, 29], geraniin [30], chebulagic acid [31], phyllanthusiin C [32], phyllanthusiin B [32], and phyllanthusiin U [27], respectively.

Table 1: Fingerprint of P. urinaria.

Compound
Retention time (min)
[M-H] m/z
MS-MS fragmentation

Gallic acid (1)
5.8
169
125, 151

Brevifolin carboxylic acid (3)
18
291
247, 291

Brevifolin (9)
23.3
247
247, 291

Phyllanthusiin E (4)
19.0
291
247, 203

Corilagin (5)
19.5
633
453, 301, 633

Geraniin (6)
20.5
951
301, 633

Chebulagic acid (7)
21.2
953
301, 633

Phyllanthusiin C (8)
22.8
925
301, 633

Phyllanthusiin B (10)
24.2
969
301, 633

Phyllanthusiin U (11)
24.6
924
301, 633

Isostrictinin (2)
14.0
633
451, 301

Ellagic acid (12)
28.7
301
301

Compound 2 (Rt at ca. 14.0 min) produced the same [M-H]-at m/z 633 as compound 5. The fragment ions at m/z 453 (M-H-Gal) and 301 (M-H-Gal-glc), corresponding to compound 5, were consistent with the structure of isostrictinin [33]. Compound 12 (Rt at 28.7 min) yielded an [M-H]-at m/z 301, consistent with a mass of 302. The same fragment pattern was shown by comparing (-)CAD-MS/MS analysis of compound 12 with the product ion spectral analysis of the fragment ion at m/z 301 (MS3) in compound 5 (corilagin). This suggested an ellagic acid moiety, and compared with the fragments in the literature [26], compound 12 was assigned as ellagic acid. The identities of compound 1 and compound 12 were further confirmed by chemical markers (mass and HPLC retention times) to be gallic and ellagic acid, respectively.

3.2. Cell Viability of Osteosarcoma 143B and 143Bρ ⁰ Cells Treated with P. urinaria

The cell viability of 143B cells was significantly inhibited by P. urinaria treatment in a dose-dependent manner. P. urinaria extract at concentrations of 2 mg/mL for 24 hours and 1 mg/mL for 48 hours caused an approximate 50% decrease (Figures 1(a) and 1(b)), respectively, in 143B cells compared to vehicle controls. Nearly complete loss of 143B and 143Bρ ⁰ cells was observed with a higher dose or longer exposure (>72 hours) to P. urinaria treatment. 143Bρ ⁰ cells, which lack mitochondrial DNA-derived from the human osteosarcoma cell line 143B, were introduced to compare the cytotoxic effect of P. urinaria. 143Bρ ⁰ cells were significantly more resistant to the cell-killing effect of P. urinaria extract following 24 hours and 48 hours treatment, compared with the parental cell line (143B) under identical culture conditions (Figures 1(a) and 1(b)). This indicated that a functional respiratory chain and active oxidative respiration were required for the cytotoxic effect induced by P. urinaria.

(a)

(b)

Figure 1: Cell viability of P. urinaria extract on 143B and 143Bρ ⁰ cells. Cells were treated with different concentrations for (a) 24 h and (b) 48 h. The cell viability was determined by standard MTT assay. The bar value is the mean ± SD of three independent experiments in duplicate. Asterisks mean statistical significance in comparison with the vehicle control (*, **). A pound sign represents a significant difference between 143B and 143Bρ ⁰ cells (#).

3.3. Induction of Apoptosis by P. urinaria

It is well known that a cytotoxic effect is associated with intrinsic and extrinsic stimulations to result in apoptosis. In order to confirm apoptosis induced by P. urinaria, we next determined whether 143B and 143Bρ ⁰ cells displayed a differential sensitivity to P. urinaria-induced apoptosis through annexin V/PI staining and TUNEL assay. As shown in Figures 2(a) and 2(b), the apoptotic cell count of 143B cells was significantly increased by P. urinaria treatment after incubation for 24 and 48 hours by staining with annexin V, which binds to phosphatidylserine with high affinity. We also compared the cytotoxic effects of P. urinaria on 143Bρ ⁰ cells. The results showed that P. urinaria exhibited no cytotoxic effect on 143Bρ ⁰ cells with 3 mg/mL P. urinaria treatment for 24 hours incubation (Figure 2(a)). However, a concentration higher than 2 mg/mL of P. urinaria with 48 hours treatment did inhibit 143Bρ ⁰ cell growth, but less than for 143B cells (Figure 2(b)). This suggested that parental 143B cells were more sensitive to P. urinaria-induced apoptosis than 143Bρ ⁰ cells (Figures 2(c) and 2(d)). DNA fragmentation, which is the hallmark of apoptosis, by TUNEL and DAPI staining used to detect all nuclei was introduced to further analyze 143B and 143Bρ ⁰ cells with P. urinaria treatment. The results demonstrated a significant increase of apoptosis in 143B cells with a higher concentration and longer exposure to P. urinaria treatment than in 143Bρ ⁰ cells (Figures 2(e) and 2(f)). Taken together, our results indicated that the amount of apoptosis in 143B cells was markedly increased in response to P. urinaria treatment compared to 143Bρ ⁰ cells.

(a)

(b)

(c)

(d)

(e)

(f)

Figure 2: Apoptosis of 143B and 143Bρ ⁰ cells of P. urinaria detected by flow cytometry with annexin V and propidium iodide (PI) and TUNEL staining. 143B and 143Bρ ⁰ cells treated with P. urinaria for 24 h (a) and 48 h (b) are shown with representative dot plots from FITC-conjugated annexin V and PI staining. Early apoptosis was recognized in the presence of staining for annexin V and absence of staining for PI. Late apoptosis was recognized in the presence of staining for both annexin V and PI. The percentage of apoptosis from flow cytometric analysis for 24 h (c) and 48 h (d) was assessed. Values are mean ± SD of three independent experiments in duplicate. Asterisks represent statistical significance from the vehicle control (*, **). A pound sign represents statistical significance between 143B and 143 Bρ ⁰ cells (#). Immunofluorescence showing apoptotic 143B and 143Bρ ⁰ cells marked by TUNEL assay in the absence and presence of 2 mg/mL P. urinaria treatment for 24 h (e) and 48 h (f) are indicated. DAPI staining was used to detect all nuclei and visualized under a fluorescence microscope (1000x). DNA damage of 143B cells in comparison with 143 Bρ ⁰ cells was markedly increased with the treatment of P. urinaria (#).

3.4. Change of Intracellular ROS Levels in 143B and 143Bρ ⁰ Cells

Recently, P. urinaria has been reported to inhibit HepG2 cells by acting as an inhibitor of oxidative phosphorylation and a weak mitochondrial uncoupler [13]. To address whether P. urinaria enhances ROS generation in 143B and 143Bρ ⁰ cells, the intracellular H₂O₂ concentration was detected by DCFDA-based flow cytometric analysis. As shown in Figures 3(a) and 3(b), the more significant shift of mean fluorescence intensity (MFI) in 143B cells with P. urinaria treatment demonstrated enhancement of ROS levels in a both dose- and time-dependent manner, but not in 143Bρ ⁰ cells. This indicated that the generation of intracellular ROS increased in 143B cells with P. urinaria treatment compared to 143Bρ ⁰ cells. As the relevance of the ROS-generating sites in mitochondria may be different from those producing ROS in living cells, we further examined the levels of mitochondrial superoxide with MitoSOX fluorescence. The results demonstrated that P. urinaria triggered superoxide production in mitochondria to inhibit cell proliferation in 143B cells, but to a lesser extent in 143Bρ ⁰ cells (Figures 3(c) and 3(d)).

(a)

(b)

(c)

(d)

(e)

(f)

Figure 3: Effects of 143B and 143Bρ ⁰ cells with P. urinaria-induced intracellular and mitochondrial ROS generation and mitochondrial membrane potential. The intracellular ROS with DCFDA staining by FACS analysis in 143B and 143Bρ ⁰ cells for 24 (a) and 48 (b) hours. The values are displayed as the mean ± SD of the mean fluorescence intensity of DCF. 143B and 143Bρ ⁰ cells were preincubated with MitoSOX Red and DAPI in the absence or presence of P. urinaria 2 mg/mL treatment for 24 (c) and 48 (d) hours. Representative digital images of MitoSOX and DAPI fluorescence were obtained using a fluorescence microscope (1000x). The mitochondrial membrane potential (ΔΨm) stained with Rhodamine 123 by FACS analysis in 143B and 143Bρ ⁰ cells for 24 (e) and 48 (f) hours. The values are displayed as the mean ± SD of percent control on intracellular ROS and mitochondrial membrane potential. Three independent experiments in duplicate were performed. Asterisks represent statistical significance from the vehicle control (*, **). A pound sign represents statistical significance between 143B and 143Bρ ⁰ cells (#).

3.5. Decreased Mitochondrial Membrane Potential in 143B and 143Bρ ⁰ Cells

In our previous study [14], we found that P. urinaria-induced apoptosis might be correlated with the loss of mitochondrial transmembrane potential to activate the mitochondria-dependent intrinsic pathway. In this study, P. urinaria resulted in a uniform reduction in mitochondrial membrane potential in parental 143B cells in a time- and dose-dependent manner (Figures 3(e) and 3(f)). Maintenance of mitochondrial potential of 143 Bρ ⁰ cells was unaffected by incubation with P. urinaria for 24 hours. However, a decrease of mitochondrial membrane potential of 143Bρ ⁰ cells was noted in response to 2 or 3 mg/mL incubation with P. urinaria for 48 hours, but not as prominently in comparison with 143B cells (Figures 3(e) and 3(f)).

3.6. Effects of P. urinaria on the Protein Expressions of Fas Receptor and Fas Ligand

The critical elements of the Fas pathway that link receptor/ligand interaction and downstream activation of caspases including caspase-3 were identified in our previous report [34]. To further elucidate the molecular mechanism underlying the P. urinaria-induced apoptosis in 143B and 143Bρ ⁰ cells, we examined the protein expressions of Fas receptor/ligand by Western blot, immunofluorescence, and flow cytometry analysis. The protein expressions of both Fas receptor and ligand were induced by the treatment of P. urinaria in 143B cells. However, Fas receptor and ligand were triggered less prominently by the treatment of P. urinaria in 143Bρ ⁰ cells (Figures 4(a) and 4(b)), whereas both Fas receptor and ligand expressions were increased at the surface of 143B cells, but to the lesser extent in 143Bρ ⁰ cells (Figures 4(c), 4(d), 4(e), 4(f)). Flow cytometry analysis of the Fas ligand in 143B and 143ρ ⁰ cells exposed to 2 mg/mL P. urinaria confirmed the Western blot and immunofluorescence data (Figures 4(g) and 4(h)). These observations indicated that P. urinaria-induced death was dependent upon Fas receptor/ligand interactions through an extrinsic pathway.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 4: P. urinaria enhanced the Fas and FasL expression in 143B cells, but to a lesser extent in 143Bρ ⁰ cells. Cell lysates treated with P. urinaria for 24 hours (a) and 48 hour (b) were subjected to Western blot analysis. Cells were pretreated with P. urinaria for 24 (c, e) and 48 (d, f) hours and incubated with Fas or FasL antibodies one hour before harvest and then stained for Fas or FasL with anti-IgG3 Alexa 546- or 488-conjugated secondary antibodies (red or green). DAPI staining was used to detect all nuclei and visualized under a fluorescence microscope (1000x). Flow cytometry analysis of surface FasL. Quantitation of surface FasL levels in 143 B and 143Bρ ⁰ cells treated with P. urinaria for 24 (g) and 48 (h) hours after Alexa 488-conjugated secondary antibodies was determined by flow cytometry analysis. An asterisk represents statistical significance from the vehicle control (**). A pound sign represents statistical significance between 143B and 143Bρ ⁰ cells (#).

3.7. Effects of P. urinaria on the Protein Expressions of Bcl-2 Family and Cysteine-Aspartic Proteases in 143B and 143Bρ ⁰ Cells

To further investigate the molecular mechanism responsible for the P. urinaria-induced apoptosis in 143B and 143Bρ ⁰ cells, the protein expression of the Bcl-2 family was analyzed by Western blot. Members of the Bcl-2 family, including proapoptotic (Bid, Bax, and Bak) and anti-apoptotic (Bcl-2 and Bcl-xL) proteins, are critical regulators of the intrinsic pathway to modulate the permeabilization of mitochondrial membranes [14]. P. urinaria treatment led to the upregulation of proapoptotic protein expression such as Bax, Bid, while apoptotic proteins including Bcl-2 were downregulated in a time- and dose-dependent manner (Figures 5(a) and 5(b)), which therefore resulted in the relative increase of Bax/Bcl-2 ratio in 143B cells, but not obviously in 143Bρ ⁰ cells. Additionally, the induction of apoptosis typically leads to the activation of the caspase cascade. We demonstrated cleaved caspase 3, 8, and 9 activation induced by P. urinaria in 143B cells (Figures 5(a) and 5(b)); however, cleaved caspase 3, 8, and 9 in 143Bρ ⁰ cells treated with P. urinaria were less activated in comparison with 143B cells. Apoptosis induced through the Fas receptor/ligand activates caspase-8 and leads to the release of the caspase-8 active fragments. Upon apoptotic stimulation, cytochrome c released from mitochondria associates with the 47 kDa procaspase-9/Apaf 1. Apaf-1-mediated activation of caspase-9 involves intrinsic proteolytic process. Additional cleavage occurs at Asp330 producing 37 kDa subunit that can serve to amplify the apoptotic response. To better correlate caspase activation with induction of apoptotic cell death, we examined caspase-3 expression in 143B cells treated with the caspase-3 inhibitor Z-DEVD-fmk (10 μmol/L), caspase-8 inhibitor Z-IETD-fmk (10 μmol/L), caspase-9 inhibitor Z-LEHD-fmk (10 μmol/L), and pan caspase inhibitor Z-VAD-fmk (10 μmol/L) for 2 hours, followed by with or without 2 mg/mL of P. urinaria for 24 hours. Pretreatment with caspase inhibitors sharply suppressed caspase-3 expression in Western blots (Figure 6).

(a)

(b)

Figure 5: The effects of apoptosis-related protein expression in 143B and 143Bρ ⁰ cells. Cells were treated with the indicated concentrations of P. urinaria for 24 hours (a) and 48 hours (b). Cell lysates were subjected to Western blot analysis using antibodies including caspase-3, caspase 8, caspase 9, Bax, Bcl-2, Bid, tBid and β-actin antibodies. The Western blot data represent one of the three independent experiments.

Figure 6: Caspase inhibitors decreased apoptosis inducing by P. urinaria in 143B cells. The representative Western blot analyses demonstrating the effects of the caspase-3, 8, 9 inhibitors including Z-DEVD-FMK, Z-IETD-FMK, Z-LEHD-FMK and the pan-caspase inhibitor Z-VAD-FMK on caspase-3 expression in 143B cells treated without or with 2 mg/mL P. urinaria. The Western blot data represent one of the three independent experiments.

4. Discussion

Numerous naturally occurring botanic extracts are recognized to be antioxidants, cancer preventive agents, or are even used as a cancer therapy drugs such as paclitaxel and vincristine [35]. It is now well established that a disruption of the apoptotic process is involved in neoplastic transformation and tumor growth [23]. In recent years, there has been increasing interest in many compounds from medicinal or dietary plants which possess potential chemopreventive properties. For example, shikonin, honokiol, gallic acid, and ellagic acid have all been shown to inhibit tumor proliferation in diverse cell model [26, 36–38]. However, consistency in composition and biological activity are essential requirements for the safe and effective application of medications. We used high-performance liquid chromatography-mass spectrometry (HPLC/MS) to characterize the twelve compounds in P. urinaria as a fingerprint and to ascertain batch-to-batch quality control (Table 1). P. urinaria has also been reported in many studies to possess antitumor activity [4, 6, 12, 14, 39]. In our previous investigations, P. urinaria inhibited many human cancer cells including HL-60, Molt-3, HT 1080, K-562, HepG2, and NPC-BM1 in vitro [13, 14] with morphological changes and DNA fragmentation, but not normal cells including endothelial cells (HUVECs) and liver cells (WRL68) [12]. Based on our former research, gallic acid and ellagic acid were supposed to be the most effective compounds in the P. urinaria to induce the cytotoxic effect of NPC-BM1 cells [37]. In the present study, apoptosis of osteosarcoma 143B cells was also triggered by P. urinaria.

In our previous report [34], we found that the gene expressions of both Fas receptor and ligand were increased by the treatment of P. urinaria in HL-60 cells and tightly associated with the event of apoptosis through a ceramide-related pathway. The Fas receptor/ligand signaling system [40] is an important mediator of cell apoptosis by extrinsic stimulation. By the Fas receptor-ligand linkage, Fas activates apoptotic signaling through a cytoplasmic death domain that interacts with signaling adaptors such as Fas-associated protein with death domain (FADD) to play a critical role in the downstream activation of the caspase cascade. Procaspase-8 binds to Fas-bound FADD leading to the activation of caspase-8 to stimulate a caspase cascade and subsequently leads to cell dismantling, DNA degradation, and ultimately cell death. Herein, we demonstrated that P. urinaria triggered apoptosis of 143B cells through Fas receptor/ligand expressions and induced downstream caspase 3, 8, and 9 activation. This indicates that P. urinaria induced apoptosis through both intrinsic and extrinsic mechanisms. Additionally, using the mitochondrial defective 143Bρ ⁰ cells, we provided supporting evidence that mitochondrial respiratory function and the intrinsic pathway may be essential for the anticancer effect of P. urinaria.

In the present study, we demonstrated increasing protein levels of tBid, Bid, and Bax, and decreasing protein levels of Bcl-2. In the intrinsic pathway, a death signal can also be induced by Fas receptor/ligand on the cell membrane and activate apoptotic signals, which cause procaspase-8 cleavage into caspase-8. Then, caspase-8 activates caspase-3 directly or triggers mitochondrial signal amplification such as the Bcl-2 family [41–43] to disrupt transmembrane potential and open the mitochondrial permeability transition pores responsible for releasing apoptogenic factors, such as cytochrome C, into the cytosol [41]. Following cleavage by caspase-8, the BH3-only protein, Bid, is known to activate Bax [42]. Bid is located in the cytosol and is activated by caspase-8 cleavage upon engagement of cell surface death receptors to stimulate Bax translocation to the mitochondrion regulated by tBid. Then, it undergoes oligomerization to induce the release of cytochrome C to the cytosol to activate caspase-9 and caspase-3. Bcl-2 proteins predominantly localize on the outer mitochondrial membrane, and mediate antiapoptotic effects by stabilizing the mitochondrial membrane, inhibiting permeability transition pore ability and the release of cytochrome c [21]. The balance of proapoptotic Bax and antiapoptotic Bcl-2 is known to be important in determining whether cells die or survive. The Bax/Bcl-2 ratio in a cell acts to regulate its own susceptibility to apoptosis [44]. Therefore, the relative increase of apoptotic Bax/Bcl-2 ratio was correlated well with P. urinaria-induced apoptosis in 143B cells.

Mitochondrial membrane potential change can result from oxidative stress-induced apoptotic signaling that is consequent to ROS increases and/or antioxidant decreases, disruption of intracellular redox homeostasis, and irreversible oxidative modifications of lipids, proteins, or DNA [17]. To further clarify the correlation between P. urinaria and mitochondria, we used DCF fluorescence and MitoSOX (mitochondria-targeted superoxide-specific fluorescent probe) Red to determine the intracellular and mitochondrial ROS in this study. Both intracellular and mitochondrial ROS were increased after treatment with P. urinaria. This result may provide evidence that an accumulation of reactive oxygen species can induce MPT pore opening to induce apoptosis through a mitochondria-associated (intrinsic) pathway, which is compatible with our previous results where cyclosporin A blocked opening which protected cells from death [14, 21, 22]. In contrast, P. urinaria failed to induce intracellular and mitochondrial ROS and subsequently to decrease membrane potential in 143Bρ ⁰ cells, indicating that mitochondrial respiration plays an important role in inducing cell death by P. urinaria.

Based on the present results and previous findings, we have summarized the apoptotic signaling pathway by P. urinaria in human osteosarcoma 143B cells. Initially, P. urinaria triggers Fas ligand binding with its receptor through an intracellular adaptor protein (FADD) to activate caspase-8. The activated caspase-8 truncates Bid to activate Bax that binds with the outer membrane of the mitochondrion and is able to open the mitochondrial permeability transition pore in the membrane to release cytochrome C to the cytosol. The balance of proapoptotic Bax and antiapoptotic Bcl-2 was also associated with apoptosis. An increase of the Bax/Bcl-2 ratio acted to regulate its own susceptibility to amplify the mitochondrial apoptotic pathway to release caspase-9 and downstream effecter caspase-3 to induce apoptosis of 143B cells. Furthermore, P. urinaria-induced ROS generation and apoptosis were significantly attenuated in mitochondrial function-deficient (143Bρ ⁰) cells. This suggests that the ability of P. urinaria to induce 143B apoptosis might be closely related to normal mitochondrial function. Taken together, the mechanism of the anti-tumor effect by P. urinaria was modulated by apoptosis through both extrinsic and intrinsic pathways. Our results also indicate the importance of intact mtDNA for the mechanism of the anti-tumor effect by P. urinaria and might contribute to effective therapeutic strategies for osteosarcoma, which is one of tough malignancies with few effective treatments.

Author’s Contributions

Hsin-Yi Wu and Tsu-Kung Lin contributed equally to this work.

Acknowledgments

The authors would like to thank Malcolm Higgins for the critical reading and correction of the paper. This work was supported by Chang Gung Memorial Hospital with CMRPG 880811, 880812, 890692, and 891121.

References

M. Wang, H. Cheng, Y. Li, L. Meng, G. Zhao, and K. Mai, “Herbs of the genus Phyllanthus in the treatment of chronic hepatitis B: observations with three preparations from different geographic sites,” Journal of Laboratory and Clinical Medicine, vol. 126, no. 4, pp. 350–352, 1995.

M. A. Dias, A. H. Campos, V. C. Filho, R. A. Yunes, and J. B. Calixto, “Analysis of the mechanisms underlying the contractile response induced by the hydroalcoholic extract of Phyllanthus urinaria in the guinea-pig urinary bladder in-vitro,” Journal of Pharmacy and Pharmacology, vol. 47, no. 10, pp. 846–851, 1995.

J. B. Calixto, A. R. S. Santos, V. C. Filho, and R. A. Yunes, “A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential,” Medicinal Research Reviews, vol. 18, no. 4, pp. 225–258, 1998.

L. Chularojmontri, S. K. Wattanapitayakul, A. Herunsalee, S. Charuchongkolwongse, S. Niumsakul, and S. Srichairat, “Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity,” Biological and Pharmaceutical Bulletin, vol. 28, no. 7, pp. 1165–1171, 2005.

K. J. Jeena, K. L. Joy, and R. Kuttan, “Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis,” Cancer Letters, vol. 136, no. 1, pp. 11–16, 1999.

N. V. Rajeshkumar and R. Kuttan, “Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma,” Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 215–219, 2000.

G. R. Pettit, D. E. Schaufelberger, R. A. Nieman, C. Dufresne, and J. A. Saenz-Renauld, “Antineoplastic agents, 177. Isolation and structure of phyllanthostatin 6,” Journal of Natural Products, vol. 53, no. 6, pp. 1406–1413, 1990.

G. Powis and D. J. Moore, “High-performance liquid chromatographic assay for the antitumor glycoside phyllanthoside and its stability in plasma of several species,” Journal of Chromatography, vol. 342, no. 1, pp. 129–134, 1985.

P. Giridharan, S. T. Somasundaram, K. Perumal et al., “Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis,” British Journal of Cancer, vol. 87, no. 1, pp. 98–105, 2002.

S. Y. Lin, C. C. Wang, Y. L. Lu, W. C. Wu, and W. C. Hou, “Antioxidant, anti-semicarbazide-sensitive amine oxidase, and anti-hypertensive activities of geraniin isolated from Phyllanthus urinaria,” Food and Chemical Toxicology, vol. 46, no. 7, pp. 2485–2492, 2008.

R. Srirama, U. Senthilkumar, N. Sreejayan et al., “Assessing species admixtures in raw drug trade of Phyllanthus, a hepato-protective plant using molecular tools,” Journal of Ethnopharmacology, vol. 130, no. 2, pp. 208–215, 2010.

S. T. Huang, R. C. Yang, and J. H. S. Pang, “Aqueous extract of Phyllanthus urinaria induces apoptosis in human cancer cells,” American Journal of Chinese Medicine, vol. 32, no. 2, pp. 175–183, 2004.

N. Chudapongse, M. Kamkhunthod, and K. Poompachee, “Effects of Phyllanthus urinaria extract on HepG2 cell viability and oxidative phosphorylation by isolated rat liver mitochondria,” Journal of Ethnopharmacology, vol. 130, no. 2, pp. 315–319, 2010.

S. T. Huang, R. C. Yang, L. J. Yang, P. N. Lee, and J. H. S. Pang, “Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells,” Life Sciences, vol. 72, no. 15, pp. 1705–1716, 2003.

Y. Q. Tang, I. B. Jaganath, and S. D. Sekaran, “Phyllanthus spp. induces selective growth inhibition of PC-3 and mewo human cancer cells through modulation of cell cycle and induction of apoptosis,” PLoS ONE, vol. 5, no. 9, Article ID e12644, pp. 1–11, 2010.

S. Nagata, “Apoptosis by death factor,” Cell, vol. 88, no. 3, pp. 355–365, 1997.

M. L. Circu and T. Y. Aw, “Reactive oxygen species, cellular redox systems, and apoptosis,” Free Radical Biology and Medicine, vol. 48, no. 6, pp. 749–762, 2010.

N. N. Danial and S. J. Korsmeyer, “Cell death: critical control points,” Cell, vol. 116, no. 2, pp. 205–219, 2004.

C. Du, M. Fang, Y. Li, L. Li, and X. Wang, “Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition,” Cell, vol. 102, no. 1, pp. 33–42, 2000.

D. R. Hunter, R. A. Haworth, and J. H. Southard, “Relationship between configuration, function, and permeability in calcium treated mitochondria,” Journal of Biological Chemistry, vol. 251, no. 16, pp. 5069–5077, 1976.

J. S. Kim, L. He, and J. J. Lemasters, “Mitochondrial permeability transition: a common pathway to necrosis and apoptosis,” Biochemical and Biophysical Research Communications, vol. 304, no. 3, pp. 463–470, 2003.

J. J. Lemasters, T. P. Theruvath, Z. Zhong, and A. L. Nieminen, “Mitochondrial calcium and the permeability transition in cell death,” Biochimica et Biophysica Acta, vol. 1787, no. 11, pp. 1395–1401, 2009.

G. Evan and T. Littlewood, “A matter of life and cell death,” Science, vol. 281, no. 5381, pp. 1317–1322, 1998.

H. L. Li, Flora of Taiwan (II), Editorial Committee of the Flora of Taiwan, Taipei, Taiwan, 2nd edition, 1993.

M. P. King and G. Attardi, “Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation,” Science, vol. 246, no. 4929, pp. 500–503, 1989.

S. T. Huang, C. Y. Wang, R. C. Yang et al., “Ellagic acid, the active compound of phyllanthus urinaria, exerts in vivo anti-angiogenic effect and inhibits MMP-2 activity,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 215035, 10 pages, 2011.

H. Luo, L. Chen, Z. Li, Z. Ding, and X. Xu, “Frontal immunoaffinity chromatography with mass spectrometric detection: a method for finding active compounds from traditional Chinese herbs,” Analytical Chemistry, vol. 75, no. 16, pp. 3994–3998, 2003.

L. Z. Zhang, Y. J. Guo, G. Z. Tu, F. Miao, and W. B. Guo, “Isolation and identification of a noval polyphenolic compound from Phyllanthus urinaria L,” China Journal of Chinese Materia Medica, vol. 25, no. 12, pp. 724–725, 2000.

R. Isobe, T. Tanaka, G. I. Nonaka, and I. Nishioka, “A new method for structural study of hydrolyzable tannins by negative fast atom bombardment mass spectroscopy,” Chemical & Pharmaceutical Bulletin, vol. 37, pp. 1748–1750, 1989.

T. Yoshida, H. Itoh, S. Matsunaga, R. Tanaka, and T. Okuda, “Tannins and related polyphenols of euphorbiaceous plants. IX. Hydrolyzable tannins with 1C4 glucose core from Phyllanthus flexuosus Muell. Arg,” Chemical and Pharmaceutical Bulletin, vol. 40, no. 1, pp. 53–60, 1992.

Y. J. Zhang, T. Nagao, T. Tanaka, C. R. Yang, H. Okabe, and I. Kouno, “Antiproliferative activity of the main constituents from Phyllanthus emblica,” Biological and Pharmaceutical Bulletin, vol. 27, no. 2, pp. 251–255, 2004.

K. C. S. C. Liu, M. T. Lin, S. S. Lee, J. F. Chiou, S. Ren, and E. J. Lien, “Antiviral tannins from two Phyllanthus species,” Planta Medica, vol. 65, no. 1, pp. 43–46, 1999.

L. Z. Zhang, Y. J. Guo, G. Z. Tu, W. B. Guo, and F. Miao, “Studies on chemical constituents of Phyllanthus urinaria L,” China Journal of Chinese Materia Medica, vol. 25, no. 10, pp. 615–617, 2000.

S. T. Huang, R. C. Yang, M. Y. Chen, and J. H. S. Pang, “Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptosis in HL-60 cells,” Life Sciences, vol. 75, no. 3, pp. 339–351, 2004.

M. A. I. AbouEl Hassan, S. R. Braam, and F. A. E. Kruyt, “Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells,” Cancer Gene Therapy, vol. 13, no. 12, pp. 1105–1114, 2006.

I. C. Chang, Y. J. Huang, T. I. Chiang, C. W. Yeh, and L. S. Hsu, “Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells,” Biological and Pharmaceutical Bulletin, vol. 33, no. 5, pp. 816–824, 2010.

S. T. Huang, C. Y. Wang, R. C. Yang, C. J. Chu, H. T. Wu, and J. H. Pang, “Phyllanthus urinaria increases apoptosis and reduces telomerase activity in human nasopharyngeal carcinoma cells,” Forschende Komplementärmedizin, vol. 16, no. 1, pp. 34–40, 2009.

Y. J. Chen, C. L. Wu, J. F. Liu et al., “Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress,” Cancer Letters, vol. 291, no. 1, pp. 20–30, 2010.

S. T. Huang, R. C. Yang, P. N. Lee et al., “Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma,” International Immunopharmacology, vol. 6, no. 6, pp. 870–879, 2006.

P. H. Krammer, J. Dhein, H. Walczak et al., “The role of APO-1-mediated apoptosis in the immune system,” Immunological Reviews, no. 142, pp. 175–191, 1994.

C. Scaffidi, S. Fulda, A. Srinivasan et al., “Two CD95 (APO-1/Fas) signaling pathways,” EMBO Journal, vol. 17, no. 6, pp. 1675–1687, 1998.

A. H. Stegh, B. C. Barnhart, J. Volkland et al., “Inactivation of caspase-8 on mitochondria of Bcl-XL-expressing MCF7-Fas cells role for the bifunctional apoptosis regulator protein,” Journal of Biological Chemistry, vol. 277, no. 6, pp. 4351–4360, 2002.

S. Létuvé, A. Druilhe, M. Grandsaigne, M. Aubier, and M. Pretolani, “Involvement of caspases and of mitochondria in Fas ligation-induced eosinophil apoptosis: modulation by interleukin-5 and interferon-γ,” Journal of Leukocyte Biology, vol. 70, no. 5, pp. 767–775, 2001.

W. W. L. Wong and H. Puthalakath, “Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway,” IUBMB Life, vol. 60, no. 6, pp. 390–397, 2008.